Mobileye Global Valuation
Is MBLY * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MBLY * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MBLY * (MX$612.15) is trading below our estimate of fair value (MX$1078.61)
Significantly Below Fair Value: MBLY * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MBLY *?
Other financial metrics that can be useful for relative valuation.
What is MBLY *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$22.76b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 11.6x |
Enterprise Value/EBITDA | -284.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does MBLY *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.2x | ||
NEMAK A Nemak S. A. B. de C. V | 0.09x | 1.3% | Mex$8.6b |
GISSA A Grupo Industrial Saltillo. de | 0.3x | n/a | Mex$6.3b |
APTV Aptiv | 0.9x | 7.3% | US$20.3b |
600660 Fuyao Glass Industry Group | 3.5x | 12.3% | CN¥118.6b |
MBLY * Mobileye Global | 12.2x | 22.3% | Mex$22.8b |
Price-To-Sales vs Peers: MBLY * is expensive based on its Price-To-Sales Ratio (12.2x) compared to the peer average (1.2x).
Price to Earnings Ratio vs Industry
How does MBLY *'s PE Ratio compare vs other companies in the Global Auto Components Industry?
Price-To-Sales vs Industry: MBLY * is expensive based on its Price-To-Sales Ratio (12.2x) compared to the Global Auto Components industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is MBLY *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 12.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate MBLY *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$612.15 | Mex$696.26 +13.7% | 16.6% | Mex$978.55 | Mex$406.19 | n/a | 25 |
Jun ’25 | n/a | Mex$651.90 0% | 18.4% | Mex$950.35 | Mex$373.35 | n/a | 26 |
May ’25 | n/a | Mex$652.49 0% | 18.6% | Mex$953.12 | Mex$374.44 | n/a | 26 |
Apr ’25 | n/a | Mex$635.69 0% | 21.2% | Mex$964.63 | Mex$365.89 | n/a | 25 |
Mar ’25 | n/a | Mex$660.03 0% | 21.4% | Mex$989.86 | Mex$375.47 | n/a | 23 |
Feb ’25 | n/a | Mex$669.06 0% | 21.3% | Mex$998.91 | Mex$378.90 | n/a | 23 |
Jan ’25 | n/a | Mex$842.74 0% | 13.3% | Mex$1,226.33 | Mex$630.20 | n/a | 24 |
Dec ’24 | n/a | Mex$840.54 0% | 13.4% | Mex$1,233.50 | Mex$633.88 | n/a | 24 |
Nov ’24 | n/a | Mex$884.20 0% | 13.7% | Mex$1,303.67 | Mex$669.94 | n/a | 24 |
Oct ’24 | n/a | Mex$853.62 0% | 13.5% | Mex$1,263.97 | Mex$596.88 | n/a | 24 |
Sep ’24 | n/a | Mex$812.49 0% | 13.5% | Mex$1,206.71 | Mex$569.84 | n/a | 23 |
Aug ’24 | n/a | Mex$808.69 0% | 13.5% | Mex$1,201.06 | Mex$567.17 | n/a | 23 |
Jul ’24 | n/a | Mex$814.79 0% | 13.0% | Mex$1,212.43 | Mex$683.06 | n/a | 21 |
Jun ’24 | n/a | Mex$818.24 0% | 15.1% | Mex$1,253.85 | Mex$600.43 | n/a | 21 |
May ’24 | n/a | Mex$822.83 0% | 16.1% | Mex$1,272.93 | Mex$609.57 | n/a | 19 |
Apr ’24 | n/a | Mex$899.15 0% | 19.7% | Mex$1,462.09 | Mex$645.60 | n/a | 17 |
Mar ’24 | n/a | Mex$873.52 0% | 19.4% | Mex$1,413.40 | Mex$624.10 | n/a | 17 |
Feb ’24 | n/a | Mex$843.00 0% | 20.6% | Mex$1,444.47 | Mex$637.82 | n/a | 16 |
Jan ’24 | n/a | Mex$846.71 0% | 25.2% | Mex$1,521.26 | Mex$632.21 | n/a | 14 |
Dec ’23 | n/a | Mex$804.54 0% | 28.4% | Mex$1,474.99 | Mex$651.29 | n/a | 11 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.